(Q58398106)

English

Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

E Shannon

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Pankey

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

F Sandoval

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B Lutz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Immunopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

175-179

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900169-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0162-3109(99)00169-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647875%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58398106&oldid=1611907245"